TransMedics (TMDX) Other Non Operating Income (2018 - 2026)
TransMedics' (TMDX) quarterly Other Non Operating Income came in at $2.4 million in Q1 2026, down 12.47% year-on-year from $2.7 million in Q1 2025, and up 117.63% quarter-over-quarter from -$13.4 million in Q4 2025.
TransMedics (TMDX) Other Non Operating Income (2018 - 2026) Analysis & Trends
TransMedics' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 12.47% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was -$4.7 million, a 139.8% decrease from a year earlier, with the FY2025 full-year figure at -$4.4 million, down 134.4% from the prior year.
- Other Non Operating Income advanced to $2.4 million in Q1 2026 per TMDX's latest filing, from -$13.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $5.0 million in Q3 2023 and bottomed at -$13.4 million in Q4 2025.
- The 5-year median for Other Non Operating Income is $2.4 million (2026), against an average of $546000.0.
- Biggest YoY gain for Other Non Operating Income was 564.31% in 2023; the steepest drop was 872.53% in 2023.
- Year by year, Other Non Operating Income stood at $1.1 million in 2022, then tumbled by 872.53% to -$8.4 million in 2023, then jumped by 122.86% to $1.9 million in 2024, then plunged by 798.02% to -$13.4 million in 2025, then jumped by 117.63% to $2.4 million in 2026.
- Per Business Quant, the three latest TMDX Other Non Operating Income figures stand at $2.4 million (Q1 2026), -$13.4 million (Q4 2025), and $3.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.36 Mn |
| Dec 31, 2025 | -13.37 Mn |
| Sep 30, 2025 | 3.22 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.57 Mn |
| Dec 31, 2023 | -8.38 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 2.43 Mn |
| Mar 31, 2023 | 555,000.00 |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | -1.08 Mn |
| Jun 30, 2022 | -784,000.00 |
| Mar 31, 2022 | -227,000.00 |
| Dec 31, 2021 | -345,000.00 |
| Sep 30, 2021 | -249,000.00 |
| Jun 30, 2021 | 171,000.00 |